What is PMCB's relative strength rating?

PMCB ranks at the 54th percentile over 1 month, 37th percentile over 3 months, 48th percentile over 6 months, 27th percentile over 1 year against the full TickerStance CS+ADRC universe of U.S. equities.

What sector is PMCB in?

PMCB is classified under the Healthcare sector within the Pharmaceutical Products industry per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data.

Is PMCB in a leading sector?

Sector RS percentile is not available for Healthcare at this snapshot. Leading sector status (threshold: Healthcare RS ≥ 70th percentile) cannot be determined until the next sector RS pipeline run.

How volatile is PMCB?

PMCB currently shows a 20-day average daily range (ADR%) of 7.1%, a 90-day beta versus the S&P 500 of 0.89. An ADR% above 4% indicates an intraday swing-trading eligible name in the Minervini Volatility Contraction Pattern framework. ADR% and ATR% are updated daily; beta is computed over a trailing 90-day window.

Does PMCB have a seasonal pattern?

TickerStance computes PMCB's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what PMCB has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.

When did PMCB last report earnings?

PMCB most recently filed a 10-Q covering FY26 Q3 with the SEC on 2026-03-17. TickerStance sources earnings data from SEC EDGAR XBRL submissions and updates the fundamentals panel daily. The Pro dossier shows eight quarters of EPS and revenue trend, operating margin history, and a composite earnings-quality rank.

PharmaCyte Biotech, Inc. Common Stock (PMCB)

Free

Loading ticker…

Dossier · Pro

PharmaCyte Biotech, Inc. Common Stock · Healthcare · Pharmaceutical Products

$0.77▲+1.44%

Neutral · stance 47

TODAY'S READ · AS OF 2026-06-26

As of 2026-06-26, PharmaCyte Biotech, Inc. Common Stock (PMCB) has a 3-month relative strength percentile of 37 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 45. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 7.1%, relative volume 0.24×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.

PMCBPharmaCyte Biotech, Inc. Common Stock

$0.77+0.01 ▲ +1.44%

RS 37·−49% from high·+1% vs 50D

RANGE

PMCB daily OHLC, last 60 sessions
Date	Open	High	Low	Close	Volume
2026-04-01	0.67	0.74	0.67	0.69	161508.824558
2026-04-02	0.71	0.75	0.68	0.69	78506.215773
2026-04-06	0.69	0.74	0.68	0.71	121734.357
2026-04-07	0.69	0.72	0.68	0.68	19690.450704
2026-04-08	0.69	0.70	0.67	0.68	79312.334
2026-04-09	0.72	0.72	0.67	0.67	70440.662
2026-04-10	0.68	0.70	0.65	0.65	53267.26
2026-04-13	0.64	0.69	0.64	0.69	85345.158718
2026-04-14	0.69	0.73	0.68	0.68	247976.289
2026-04-15	0.69	0.80	0.68	0.76	358316.12497
2026-04-16	0.74	0.77	0.71	0.73	229417.27297
2026-04-17	0.72	0.74	0.72	0.73	54865
2026-04-20	0.70	0.77	0.70	0.76	170495.257
2026-04-21	0.75	0.77	0.73	0.77	100796.334
2026-04-22	0.75	0.79	0.74	0.78	125105
2026-04-23	0.78	0.78	0.71	0.75	55242.079719
2026-04-24	0.73	0.76	0.72	0.72	67667.934
2026-04-27	0.71	0.78	0.70	0.76	131810.962
2026-04-28	0.75	0.77	0.72	0.76	48029.434
2026-04-29	0.75	0.78	0.75	0.75	19880
2026-04-30	0.76	0.78	0.72	0.72	113887.334
2026-05-01	0.73	0.76	0.72	0.76	74417.207
2026-05-04	0.77	0.78	0.74	0.76	85563.326
2026-05-05	0.75	0.76	0.72	0.73	57777.515
2026-05-06	0.74	0.78	0.72	0.77	135973.887
2026-05-07	0.74	0.80	0.74	0.80	92946.081933
2026-05-08	0.78	0.80	0.74	0.76	59252
2026-05-11	0.75	0.77	0.67	0.69	183171.296019
2026-05-12	0.68	0.83	0.68	0.79	833272.787371
2026-05-13	0.77	0.85	0.74	0.81	459058.846027
2026-05-14	0.83	0.97	0.79	0.95	1770051.041255
2026-05-15	0.94	0.94	0.76	0.80	478434.176
2026-05-18	0.80	0.83	0.76	0.76	157441.180622
2026-05-19	0.78	0.80	0.73	0.73	210380.72409
2026-05-20	0.75	0.81	0.70	0.77	238050
2026-05-21	0.78	0.83	0.77	0.80	263120
2026-05-22	0.79	0.86	0.77	0.81	564075.67406
2026-05-26	0.80	0.81	0.77	0.79	125316.415
2026-05-27	0.79	0.80	0.76	0.76	79049.848
2026-05-28	0.76	0.86	0.76	0.86	410821.80404
2026-05-29	0.85	0.87	0.81	0.83	147298.49384
2026-06-01	0.83	0.84	0.79	0.80	90502.788
2026-06-02	0.78	0.81	0.75	0.75	129903.440316
2026-06-03	0.74	0.75	0.70	0.73	86336.352
2026-06-04	0.71	0.75	0.71	0.73	52361.374
2026-06-05	0.73	0.74	0.67	0.70	196592
2026-06-08	0.70	0.72	0.68	0.70	236431.007
2026-06-09	0.71	0.71	0.70	0.70	63320
2026-06-10	0.70	0.73	0.70	0.70	32406
2026-06-11	0.70	0.78	0.70	0.75	190970.398
2026-06-12	0.77	0.81	0.76	0.76	172947.813
2026-06-15	0.77	0.84	0.77	0.81	133320.37493
2026-06-16	0.79	0.84	0.78	0.83	150973.478144
2026-06-17	0.79	0.82	0.78	0.79	77737.234
2026-06-18	0.78	0.80	0.72	0.72	205268.68808
2026-06-22	0.72	0.80	0.71	0.77	156205.397199
2026-06-23	0.76	0.80	0.76	0.78	78219.267
2026-06-24	0.76	0.77	0.75	0.77	24347.228119
2026-06-25	0.75	0.79	0.73	0.76	75748
2026-06-26	0.73	0.78	0.72	0.77	33008.857

2026-06-26·O 0.73H 0.78L 0.72C 0.77+0.01 ▲·VOL 33.0K

SRC · EOD·126 SESSIONS · 1D

§ Seasonality

10y · since 2022

Best monthJan on averageavg +3.84% · 75% win · n 4

Worst monthAug on averageavg -6.93% · 25% win · n 4

PMCB monthly seasonality strip
	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
1	PMCB Jan avg: 3.84% median: 1.81% win: 75% σ: 6.37% n: 4 2022-04-12 → 2026-05-29	PMCB Feb avg: -1.53% median: -0.15% win: 50% σ: 11.07% n: 4 2022-04-12 → 2026-05-29	PMCB Mar avg: -5.71% median: -3.29% win: 25% σ: 17.37% n: 4 2022-04-12 → 2026-05-29	PMCB Apr avg: 0.97% median: 0.34% win: 60% σ: 7.65% n: 5 2022-04-12 → 2026-05-29	PMCB May avg: -0.54% median: -1.29% win: 40% σ: 12.86% n: 5 2022-04-12 → 2026-05-29	PMCB Jun avg: -1.38% median: -1.30% win: 25% σ: 6.42% n: 4 2022-04-12 → 2026-05-29 (current)	PMCB Jul avg: -1.68% median: -3.21% win: 25% σ: 6.42% n: 4 2022-04-12 → 2026-05-29	PMCB Aug avg: -6.93% median: -7.92% win: 25% σ: 13.11% n: 4 2022-04-12 → 2026-05-29	PMCB Sep avg: 1.27% median: -2.74% win: 50% σ: 17.34% n: 4 2022-04-12 → 2026-05-29	PMCB Oct avg: 3.53% median: -1.57% win: 50% σ: 12.93% n: 4 2022-04-12 → 2026-05-29	PMCB Nov avg: -3.25% median: -1.40% win: 50% σ: 10.36% n: 4 2022-04-12 → 2026-05-29	PMCB Dec avg: -5.50% median: -5.42% win: 0% σ: 2.28% n: 4 2022-04-12 → 2026-05-29

Fundamentals · PMCB

Does the business back the chart?

SEC EDGAR · last filing 10-Q · FY26 Q3 · period end 2026-01-31 · Latest filing 103 days old — may be pre-earnings

—

Fundamentals Growth Rank

How does growth rank vs. the universe?

Insufficient data for factor compute

View fundamental leadership map

Earnings

Are losses narrowing?

Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.

Loss narrowing

−$0.61—

24 Q4

$1.90—

25 Q1

−$0.39

Evidence · 1 of 3

Receipts behind the read

0 of 5 pass

Leadership

Is it leading?

Relative strength across horizons plus the leadership score.

LDR

—

StageWeinstein stage analysis

Stage 1 · Basing

Smart money

Who's accumulating?

Accumulation rating, relative volume, U/D ratio, breakout-day proof.

ETF OWNERS

ETFs holding PMCB

PMCB appears in 1 ETF as of Mar 2026: VXF at 0.00% weight, $34K notional.

ETFs holding: 1
Total value: $34K
Top 3 concentration: 100.0%
Max weight: VXF · 0.00%

Top 1 by value, from SEC N-PORT-P filings dated Mar 2026.

ETFs holding PMCB ranked by value
ETF	Weight	Value
VXFVanguard Extended Market ETF	0.00%	$34K

FAQ

Frequently asked questions

What is PMCB's relative strength rating?: PMCB ranks at the 54th percentile over 1 month, 37th percentile over 3 months, 48th percentile over 6 months, 27th percentile over 1 year against the full TickerStance CS+ADRC universe of U.S. equities.
What sector is PMCB in?: PMCB is classified under the Healthcare sector within the Pharmaceutical Products industry per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data.
Is PMCB in a leading sector?: Sector RS percentile is not available for Healthcare at this snapshot. Leading sector status (threshold: Healthcare RS ≥ 70th percentile) cannot be determined until the next sector RS pipeline run.
How volatile is PMCB?: PMCB currently shows a 20-day average daily range (ADR%) of 7.1%, a 90-day beta versus the S&P 500 of 0.89. An ADR% above 4% indicates an intraday swing-trading eligible name in the Minervini Volatility Contraction Pattern framework. ADR% and ATR% are updated daily; beta is computed over a trailing 90-day window.
Does PMCB have a seasonal pattern?: TickerStance computes PMCB's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what PMCB has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.
When did PMCB last report earnings?: PMCB most recently filed a 10-Q covering FY26 Q3 with the SEC on 2026-03-17. TickerStance sources earnings data from SEC EDGAR XBRL submissions and updates the fundamentals panel daily. The Pro dossier shows eight quarters of EPS and revenue trend, operating margin history, and a composite earnings-quality rank.

§ Seasonality

Does the business back the chart?

Are losses narrowing?

Receipts behind the read

Is it leading?

Who's accumulating?

PMCB is not confirmed as a leader.

Is revenue confirming?

Are margins expanding?

Share count: tailwind or headwind?

How much does it move?

Sector context

Who else is leading?

Healthcare

Same industry, closest relative strength

Market backdrop

Is the crowd watching?

Company snapshot

ETFs holding PMCB

Frequently asked questions

§ Seasonality

PharmaCyte Biotech, Inc. Common Stock (PMCB) — Stance & relative strength

Does the business back the chart?

Are losses narrowing?

Receipts behind the read

Is it leading?

Who's accumulating?

PMCB is not confirmed as a leader.

Is revenue confirming?

Are margins expanding?

Share count: tailwind or headwind?

How much does it move?

Sector context

Who else is leading?

Healthcare

Same industry, closest relative strength

Market backdrop

Is the crowd watching?

Company snapshot

ETFs holding PMCB

Frequently asked questions